References
- Dukes M NG, Haaijer-Ruskamp F M, de Joncheere C P, Rietveld A H. Drugs and Money, Prices, affordability and cost containment. IOS Press/WHO, Amsterdam 2003
- Huttin C. Experiences with reference pricing. Drugs and Money, Prices, affordability and cost containment, M NG Dukes, F M Haaijer-Ruskamp, C P de Joncheere, A H Rietveld. IOS Press/WHO, Amsterdam 2003; 85–91
- Haaijer-Ruskamp F M. Experiences with patient charges. Drugs and Money, Prices, affordability and cost containment, M NG Dukes, F M Haaijer-Ruskamp, C P de Joncheere, A H Rietveld. ISO Press/WHO, Amsterdam 2003; 93–6
- Dew K. Epidemics, panic and power: representations of measles and measles vaccines. Health 1999; 3: 379–98
- Dopson S, Locock L, Gabbay J, Ferlie E, Fitzgerald L. Evidence-based medicine and the implementation gap. Health 2003; 7: 311–30
- Audit Commission. A Prescription for Improvement, Towards more rational prescribing in general practice [report]. HMSO, London 1994
- Coulter A. The autonomous patient, ending paternalism in medical care. The Nuffield Trust, London 2002
- RPSGB. From Compliance to Concordance, Achieving Shared Goals in Medicine Taking [report]. London 1997
- Prescription Pricing Authority. Update on Growth in Prescription Volume and Cost Year to March 2002 [Report]. NHS. 2002
- Prescription Pricing Authority. PACT Centre Pages - Drugs for Dyspepsia [report]. PPA. 2002
- Chaplin A, Curless R, Thomson R, Barton R. Prevalence of lower gastrointestinal symptoms and associated consultation behaviour in a British elderly population determined by face-to-face interview. Br J Gen Pract 2000; 50: 798–802
- SIGN. Dyspepsia, A national clinical guideline. Scottish Intercollegiate Guidelines Network, Edinburgh 2003
- Ashworth M, Armstrong D, Lloyd D, Colwill S. The effects on GP prescribing of joining a commissioning group. J Clin Pharm Ther 2002; 27: 221–8
- Bashford J NR, Norwood J, Chapman S R. Why are patients prescribed proton pump inhibitors? Retrospective analysis of link between morbidity and prescribing in the General Practice Research Database. BMJ 1998; 317: 452–6
- Mc Manus P, Marley J, Birkett D J, Lindner J. Compliance with restrictions on the subsidized use of proton pump inhibitors in Australia. Br J Clin Pharmacol 1998; 46: 409–11
- Westbrook J I, Duggan A E, McIntosh J H. Prescriptions for antiulcer drugs in Australia: volume, trends, and costs. BMJ 2001; 323: 1338–9
- NICE. Guidance on the Use of Proton Pump Inhibitors in the Treatment of Dyspepsia [report]. NHS, London 2000
- Pollock K, Grime J. Strategies for reducing the prescribing of proton pump inhibitors (PPIs): patient self-regulation of treatment may be an under-exploited resource. Soc Sci Med 2000; 51: 1827–39
- Ginsburg M E, Kravitz R L, Sandberg W A. A survey of physician attitudes and practices concerning cost-effectiveness in patient care. West J Med 2000; 173: 390–4
- Pollock K, Grime J, Blenkinsopp A. Proton Pump Inhibitors: Perspectives of Patients and their GPs [report]. Department of Medicines Management, Keele University. 1998
- Butler C, Rollnick S, Pill R, Maggs-Rapport F, Stott N. Understanding the culture of prescribing: qualitative study of general practitioners' and patients' perceptions of antibiotics for sore throats. BMJ 1998; 317: 637–42
- Weiss M, Scott D. Whose rationality? A qualitative analysis of general practitioners' prescribing. Pharmaceutical Journal 1997; 259: 339–41
- Grime J, Pollock K, Blenkinsopp A. Proton pump inhibitors: perspectives of patients and their GPs. Br J Gen Pract 2001; 51: 703–11
- Harris R A, Kuppermann M, Richter J E. Prevention of Recurrences of Erosive Reflux Esophagitis: A Cost-Effectiveness Analysis of Maintenance Proton Pump Inhibition. Am J Med 1997; 102: 78–88
- Bolin T D. Proton pump inhibitor use. BMJ 2001; 323: 1339
- Britten N, Okoumunne O. The influence of patients' hopes of receiving a prescription on doctors' perceptions and the decision to prescribe: a questionnaire survey. BMJ 1997; 315: 1506–10